Prescription Ibuprofen Tablets Recalled for Excessive Unknown Impurities
Dr. Reddy's Laboratories is recalling IBU Ibuprofen 400 mg prescription tablets due to impurity levels exceeding specifications. The recall affects 14,940 bottles distributed nationwide in the USA and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves actual manufacturing contamination with unknown impurities exceeding specification limits in a prescription medication. While no illnesses or injuries have been reported, the presence of unidentified contaminants represents a potential health risk meeting the criteria for 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling IBU (Ibuprofen) 400 mg prescription tablets distributed nationwide in the USA and Puerto Rico. The recall involves 14,940 bottles with multiple lot numbers and expiration dates between May and November 2026.
The recall was initiated due to failed quality specifications for impurities and degradation. Laboratory testing identified unknown impurity levels of 0.13% and 0.11% in affected batches, exceeding the specification limit of 0.10%.
Affected lot numbers include C2207529 and C2210993 (NDC 55111-682-01: 100-tablet bottles) and C2207530, C2210992, C2210994, C2213304, and C2213305 (NDC 55111-682-05: 500-tablet bottles). The product is manufactured in India and distributed by Dr. Reddy's Laboratories Inc. in Princeton, New Jersey.
The recalled product
- Product
- IBU (IBUPROFEN)
- Brand
- IBU
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug
- Hazard
- Affected units
- 14,940
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- a)NDC 55111-682-01 Lots C2207529
- Exp 5/31/2026
- C2210993
- Exp 9/30/2026. b)NDC 55111-682-05 Lots C2207530
- C2210992
- C2210994
- Exp 9/30/2026
- C2213304
- C2213305
- Exp 11/30/2026.
Distribution
Part of a larger recall action
This product is one of 3 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · IBU
- LowIbuprofen 600 mg tablets recalled for failed tablet specifications
FDA (Drugs) · 2024-11-27
- HighIBU Prescription Ibuprofen Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2024-09-04
- HighPrescription Ibuprofen Recalled Due to Failed Impurity Specifications
FDA (Drugs) · 2024-09-04
- ModerateDr. Reddy's Recalls IBU Ibuprofen Tablets Due to Incorrect Expiration Date
FDA (Drugs) · 2013-09-25
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · contamination
See all →- HighMedline Recalls Gynecologic Robotic Surgery Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 263 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline recalls surgical convenience kits due to potential contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 663 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02